Description

Moderator: Robert Brown, MD

Optimal immunosuppression in organ transplantation is a balance between under immunosuppression, which is associated with graft rejection, and over immunosuppression, which is associated with infection and malignancy. Initial immunosuppression is designed to strike this balance. But how should one adjust immunosuppression when this balance is perturbed and there is an acute infectious complication or malignancy?

After participating in this webinar, the learner will be able to:

• Identify risks for development of acute infectious complications and malignancy in renal transplant recipients.
• Design rational immunosuppression strategies to manage acute infectious complications in renal transplant recipients.
• Design rational immunosuppression strategies to manage malignancy in renal transplant recipients.

Speaker(s):

• Daniel C. Brennan, MD, Johns Hopkins School of Medicine